Ac. Latronico et al., NO EVIDENCE FOR ONCOGENIC MUTATIONS IN THE ADRENOCORTICOTROPIN RECEPTOR GENE IN HUMAN ADRENOCORTICAL NEOPLASMS, The Journal of clinical endocrinology and metabolism, 80(3), 1995, pp. 875-877
The mechanism(s) of tumorigenesis for the majority of adrenocortical n
eoplasms remain unknown. G-Protein-coupled receptors were recently pro
posed as candidate protooncogenes. That activating mutations of this c
lass of receptors might be important for tumor induction or progressio
n of endocrine neoplasms was strengthened by the recent identification
of such mutations in hyperfunctioning thyroid adenomas. To examine wh
ether the ACTH receptor (ACTH-R) gene could be an oncogene in human ad
renocortical tumors, we amplified by the polymerase chain reaction and
directly sequenced the entire exon of the ACTH-R gene in 25 adrenocor
tical tumors (17 adenomas and 8 carcinomas) and 2 adrenocortical cance
r cell lines. We found no missense point mutations or even silent poly
morphisms in any of the tumors and cell Lines studied. We conclude tha
t activating mutations of the ACTH-R gene do not represent a frequent
mechanism of human adrenocortical tumorigenesis.